These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2160821

  • 1. Binding of aminoalkylphosphorothioate radioprotective drugs to rodent tissue proteins.
    Livesey JC, Grunbaum Z, Krohn KA.
    Biochem Pharmacol; 1990 Jun 01; 39(11):1807-12. PubMed ID: 2160821
    [Abstract] [Full Text] [Related]

  • 2. Toxicity and biodistribution of the radioprotectors, WR2721, WR77913, and WR3689, in the CNS following intraventricular or intracisternal administration.
    Spence AM, Edmondson SW, Krohn KA, Grunbaum Z, Rasey JS, Steele JE.
    Int J Radiat Oncol Biol Phys; 1986 Sep 01; 12(9):1653-60. PubMed ID: 3019970
    [Abstract] [Full Text] [Related]

  • 3. Measurement of tissue oxidation-reduction state with carbon-13 nuclear magnetic resonance spectroscopy.
    Livesey JC, Golden RN, Shankland EG, Grunbaum Z, Richards TL, Wade RA, Krohn KA.
    Cancer Res; 1989 Apr 15; 49(8):1937-40. PubMed ID: 2539249
    [Abstract] [Full Text] [Related]

  • 4. Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913).
    Rasey JS, Grunbaum Z, Krohn KA, Menard TW, Spence AM.
    Radiat Res; 1985 Apr 15; 102(1):130-7. PubMed ID: 2984715
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689).
    Rasey JS, Krohn KA, Grunbaum Z, Spence AM, Menard TW, Wade RA.
    Radiat Res; 1986 Jun 15; 106(3):366-79. PubMed ID: 3012625
    [Abstract] [Full Text] [Related]

  • 6. Dephosphorylation of WR-2721 with mouse tissue homogenates.
    Mori T, Nikaido O, Sugahara T.
    Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1529-31. PubMed ID: 6090356
    [Abstract] [Full Text] [Related]

  • 7. Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.
    Utley JF, Marlowe C, Waddell WJ.
    Radiat Res; 1976 Nov 15; 68(2):284-91. PubMed ID: 185642
    [No Abstract] [Full Text] [Related]

  • 8. In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
    Livesey JC, Rasey JS, Vertrees S, Freeman LM, Magee S, Nelson NJ, Chin L, Grunbaum Z, Krohn KA.
    Pharmacol Ther; 1988 Nov 15; 39(1-3):215-7. PubMed ID: 2849127
    [No Abstract] [Full Text] [Related]

  • 9. Variation in normal tissue responsiveness to WR-2721.
    Yuhas JM, Afzal SM, Afzal V.
    Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1537-9. PubMed ID: 6090357
    [Abstract] [Full Text] [Related]

  • 10. In vivo dephosphorylation of WR-2721 monitored by 31P NMR spectroscopy.
    Knizner SA, Jacobs AJ, Lyon RC, Swenberg CE.
    J Pharmacol Exp Ther; 1986 Jan 15; 236(1):37-40. PubMed ID: 3001292
    [Abstract] [Full Text] [Related]

  • 11. Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug.
    Calabro-Jones PM, Aguilera JA, Ward JF, Smoluk GD, Fahey RC.
    Cancer Res; 1988 Jul 01; 48(13):3634-40. PubMed ID: 2837319
    [Abstract] [Full Text] [Related]

  • 12. Competition for polyamine uptake into rat lung slices by WR2721 and analogues.
    Wyatt I, Moore RB, Smith LL.
    Int J Radiat Biol; 1989 Mar 01; 55(3):463-72. PubMed ID: 2564041
    [Abstract] [Full Text] [Related]

  • 13. [Study of the conditions for the breakdown of mixed disulfides between aminothiol protectors and cell proteins as factors that determine the stability of the disulfide bonds].
    Kolina VB, Filippovich IV, Romantsev EF.
    Vopr Med Khim; 1976 Mar 01; 22(4):528-33. PubMed ID: 1027239
    [Abstract] [Full Text] [Related]

  • 14. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action.
    Grdina DJ, Shigematsu N, Dale P, Newton GL, Aguilera JA, Fahey RC.
    Carcinogenesis; 1995 Apr 01; 16(4):767-74. PubMed ID: 7728953
    [Abstract] [Full Text] [Related]

  • 15. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721.
    Tabachnik NF, Blackburn P, Peterson CM, Cerami A.
    J Pharmacol Exp Ther; 1982 Feb 01; 220(2):243-6. PubMed ID: 6276531
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites.
    Swynnerton NF, Huelle BK, Mangold DJ, Ludden TM.
    Int J Radiat Oncol Biol Phys; 1986 Aug 01; 12(8):1495-9. PubMed ID: 3019967
    [Abstract] [Full Text] [Related]

  • 20. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Yuhas JM.
    Cancer Res; 1980 May 01; 40(5):1519-24. PubMed ID: 6245795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.